drugset / Trial / NCT00813813
Intradiscal rhGDF-5 Phase I/II Clinical Trial
NaSingle-groupOpen-labelTreatment
Summary
Study to show the effectiveness and safety of a single injection of rhGDF5 into a degenerating single spinal disc in treating lumbar level degenerative disc disease
Timeline
- Start
- 2008-06
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RADOTERMIN | Protein / enzyme biologic | — | Other |